Based on the density and distribution of CD3+ and CD8+ T cells, the “hot and cold” classification for the tumor was postulated, which could predict clinical outcomes of patients with various cancers and “hot” indicated potential sensitivity to immunotherapy.14 The gene discussed is CD8A; the disease is neoplasm.